Comparative Effects of Spider Cage Therapy and Modified Suit Therapy in CP

Riphah International University

Status: Completed

Conditions: Cerebral Palsy

Treatments: Device: modified suits therapy; Device: spider cage

Study type: Interventional

Funder types: Other

Identifiers

NCT06198257

REC/RCR&AHS/23/0764

Details and patient eligibility

About

Spider Cage is a part of universal exercise unit. It is a suspension system, which works with use of belts, elastic cords and Thera suits (Thera suits especially for cerebral palsy). Cords are dynamic and provides an appropriate amount of support with the help of which patient can perform movement independently. Cerebral Palsy (CP) is a condition where non progressive disorders of posture caused by abnormal development of, or damage to, motor control centers of brain resulting in abnormal movements.

Full description

It will be Randomized Controlled trial in which non probability convenience sampling technique will be used. Two groups of 8 to 12 age will be formed in which participants will be randomly divided by lottery method. Group A will be given modified Thera suits and the other group B will receive spider cage therapy on trunk stability and pelvic control. Improvement will be identified by Trunk Control Measurement Scale (TCMS), Trunk impairment scale (TIS) and Gross motor function classification system. (GMFCS) level I-II. The result after statistical analysis will show that which treatment will be more effective. Results will be analyzed on SPSS 29. Data analyzed by repeated measures ANOVA

Enrollment: 32 patients

Sex: All

Ages: 8 to 12 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• • 8 to 12 years of age

  • Both male and female
  • Hemiplegic cerebral palsy according to (GMFCS) severity level I-II
  • Ability to follow instructions and participate in therapy session

Exclusion criteria

• • Presence of any medical conditions that would severely limit a child's participation in the study as vision or hearing loss, cardiac anomalies.

  • severe cognitive impairments that would hinder the participant's ability to actively participate in therapy sessions.
  • Complicated systemic disorders.
  • Uncontrollable seizures.
  • Usage of Botulinum toxin A injection within 3 months of prior

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

32 participants in 2 patient groups

group A

Active Comparator group

Description:

Spider cage therapy along with strengthening exercises

Treatment:

Device: spider cage

group B

Active Comparator group

Description:

Modified suits therapy along with strengthening exercise

Treatment:

Device: modified suits therapy